- Home
- News
- latamerica
- bone fixation
Bone Fixation Articles & Analysis
31 news found
OSSIOfiber implants utilize existing reimbursement and surgical techniques. The OSSIOfiber Hammertoe Fixation System and the OSSIOfiber Bone Pin Family (which includes the OSSIOfiber Trimmable Fixation Nail System) are also cleared for use in the United States for maintenance of alignment and fixation of bone ...
Food and Drug Administration (FDA) for maintenance of alignment and fixation of bone fractures, comminuted fractures, fragments, osteotomies, arthrodesis and bone grafts of the upper extremity, fibula, knee, ankle and foot in the presence of appropriate brace and/or immobilization. This is the third FDA clearance for the company’s ...
” The meniscus is a tissue pad between the thigh and shin bones, and once damaged, the meniscus in middle aged patients has a very limited ability to heal itself. ...
The meniscus is a tissue pad between the thigh and shin bones. Once damaged, the meniscus has a very limited ability to heal. ...
” The meniscus is a tissue pad between the thigh and shin bones. Current treatment for a damaged or torn meniscus includes pain management, physical therapy, injections, repair techniques or meniscectomy. ...
The meniscus is a tissue pad between the thigh and shin bones. Once damaged, the meniscus has a very limited ability to heal. ...
” Clinical case reports have indicated that the CurvaFix Implant achieves strong, stable fixation that follows and fills the natural curvature of each patient’s anatomy, which may immediately reduce pain, allow for earlier mobility, and improve patient recovery. ...
About Medartis: Founded in 1997 and headquartered in Basel, Switzerland, Medartis is one of the world’s leading manufacturers and providers of medical devices for surgical fixation of bone fractures for upper and lower extremities as well as for the craniomaxillofacial region. ...
LaunchPad Medical, Inc. announced that it has been awarded a $2.5 million Direct-to-Phase II Small Business Innovation Research (SBIR) grant (1R44NS115386) from the National Institute of Neurological Disorders and Stroke to advance the development of Tetranite®, its bone adhesive biomaterial technology, to improve cranial flap fixation procedures. The ...
” Acumed has the most complete selection of upper extremity fixation and specialty plates on the market* – now complemented by ExsoMed’s threaded nails, which offer minimally invasive solutions to treat fractures, fusions, and late-stage arthritic conditions. ...
P-15L Bone Graft is based on a small biomimetic peptide (P-15) technology developed by Cerapedics to support bone growth, and is designed to be used as a substitute for autologous bone. In 2015, the company’s first-generation bone graft became the first bone graft to be approved for use in the cervical ...
The data demonstrate that elderly patients in Denmark treated with i-FACTOR bone graft plus local bone had a statistically significantly higher fusion rate compared to allograft plus local bone. ...
The meniscus is a tissue pad between the thigh and shin bones. Current treatment for a damaged or torn meniscus includes pain management, physical therapy, injections, meniscal repair or transplantation techniques, or meniscectomy. ...
The BioPoly® Great Toe implant utilizes the Company’s proprietary biomaterial that is a combination of polyethylene (UHMWPE) and hyaluronic acid, thus creating a self-lubricating polymer with enhanced wear properties. Robust fixation to the bone is provided by a titanium stem which has a porous metal surface, called OsteoSync™ (Sites Medical), a ...
i-FACTOR Peptide Enhanced Bone Graft must be used inside an allograft bone ring and with supplemental anterior plate fixation. About Cerapedics Cerapedics is an ortho-biologics company focused on developing and commercializing its proprietary small peptide (P-15) technology platform. i-FACTOR Peptide Enhanced Bone Graft is the ...
It is made from medical grade polymer and, as the result of its unique materials, composite structure and design, does not require fixation to bone or soft tissues. The NUsurface Implant mimics the function of the natural meniscus and redistributes loads transmitted across the knee joint. ...
After eight months of unsuccessful surgeries and bone fixation attempts, the patient received a recommendation for amputation. ...
i-FACTOR Peptide Enhanced Bone Graft must be used inside an allograft bone ring and with supplemental anterior plate fixation. About Cerapedics Cerapedics is an ortho-biologics company focused on developing and commercializing its proprietary small peptide (P-15) technology platform. i-FACTOR Peptide Enhanced Bone Graft is the ...
i-FACTOR Peptide Enhanced Bone Graft must be used inside an allograft bone ring and with supplemental anterior plate fixation. About Cerapedics Cerapedics is an ortho-biologics company focused on developing and commercializing its proprietary small peptide (P-15) technology platform. i-FACTOR Peptide Enhanced Bone Graft is the ...
Food and Drug Administration (FDA 510k) clearance for its Photodynamic Bone Stabilization System for treatment of fractures of the pelvis, clavicle, and the small bones of the hands and feet: metacarpals, metatarsals, and phalanges. ...